Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $830.67 | 22 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Chiesi USA, Inc. | $237.81 | 3 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $157.35 | 6 | $0 (2021) |
| UCB, Inc. | $154.47 | 3 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $115.40 | 1 | $0 (2022) |
| Allergan Inc. | $109.04 | 7 | $0 (2019) |
| PFIZER INC. | $56.60 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $121.54 | 1 | Chiesi USA, Inc. ($121.54) |
| 2023 | $90.31 | 1 | Chiesi USA, Inc. ($90.31) |
| 2022 | $295.83 | 5 | UCB, Inc. ($154.47) |
| 2021 | $118.86 | 3 | AstraZeneca Pharmaceuticals LP ($118.86) |
| 2020 | $12.94 | 1 | AstraZeneca Pharmaceuticals LP ($12.94) |
| 2019 | $89.89 | 5 | PFIZER INC. ($33.44) |
| 2018 | $75.01 | 5 | Allergan Inc. ($51.85) |
| 2017 | $26.29 | 1 | Allergan Inc. ($26.29) |
All Payment Transactions
22 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/25/2024 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $121.54 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/20/2023 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $90.31 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/26/2022 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $25.96 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/24/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $115.40 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/19/2022 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Neurology | ||||||
| 05/16/2022 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $6.18 | General |
| Category: Neurology | ||||||
| 03/23/2022 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $131.53 | General |
| Category: Neurology | ||||||
| 07/28/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $92.98 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/11/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/28/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/04/2020 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/12/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $33.44 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/06/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/05/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/13/2019 | Allergan Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: ANTI-INFECTIVE | ||||||
| 01/22/2019 | Allergan Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/08/2018 | Allergan Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $10.53 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/02/2018 | Allergan Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/27/2018 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/03/2018 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $12.27 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/27/2018 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/23/2017 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $26.29 | General |
| Category: ANTI-INFECTIVE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 367 | 376 | $133,895 | $36,539 |
| 2022 | 3 | 416 | 432 | $164,562 | $47,840 |
| 2021 | 4 | 554 | 564 | $376,054 | $69,894 |
| 2020 | 5 | 442 | 461 | $680,325 | $51,918 |
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 183 | 190 | $87,210 | $24,163 | 27.7% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 112 | 113 | $35,256 | $8,886 | 25.2% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 61 | 62 | $10,230 | $3,172 | 31.0% |
| 99282 | Emergency department visit with straightforward medical decision making | Facility | 2023 | 11 | 11 | $1,199 | $317.70 | 26.5% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 233 | 244 | $111,996 | $32,712 | 29.2% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 153 | 158 | $49,296 | $14,300 | 29.0% |
| 99282 | Emergency department visit for problem of mild to moderate severity | Facility | 2022 | 30 | 30 | $3,270 | $828.75 | 25.3% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 329 | 335 | $272,200 | $49,137 | 18.1% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 178 | 181 | $78,723 | $16,832 | 21.4% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 15 | 15 | $21,552 | $2,879 | 13.4% |
| 99282 | Emergency department visit, low to moderately severe problem | Facility | 2021 | 32 | 33 | $3,579 | $1,047 | 29.3% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 263 | 278 | $517,809 | $39,713 | 7.7% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 37 | 38 | $92,291 | $6,848 | 7.4% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 37 | 37 | $41,368 | $3,337 | 8.1% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 33 | 34 | $21,517 | $1,531 | 7.1% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 72 | 74 | $7,340 | $489.10 | 6.7% |
About Dr. Jessica Meador, D.O
Dr. Jessica Meador, D.O is a Emergency Medicine healthcare provider based in Lawton, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2016. The National Provider Identifier (NPI) number assigned to this provider is 1952751455.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jessica Meador, D.O has received a total of $830.67 in payments from pharmaceutical and medical device companies, with $121.54 received in 2024. These payments were reported across 22 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($830.67).
As a Medicare-enrolled provider, Meador has provided services to 1,779 Medicare beneficiaries, totaling 1,833 services with total Medicare billing of $206,191. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Location Lawton, OK
- Active Since 06/15/2016
- Last Updated 09/30/2020
- Taxonomy Code 207P00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1952751455
Products in Payments
- CLEVIPREX (Drug) $237.81
- LOKELMA (Drug) $157.35
- Briviact (Drug) $154.47
- XARELTO (Drug) $115.40
- ELIQUIS (Drug) $56.60
- TEFLARO (Drug) $55.18
- DALVANCE (Drug) $41.59
- AVYCAZ (Drug) $12.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Lawton
Dr. Jeffrey Golightly, M.d, M.D
Emergency Medicine — Payments: $2,236
Daniel Dorton
Emergency Medicine — Payments: $631.71
Matthew Wood, D.o, D.O
Emergency Medicine — Payments: $529.56
Dr. William Murry, D.o, D.O
Emergency Medicine — Payments: $436.95
Jordan Price, Do, DO
Emergency Medicine — Payments: $428.66
Dr. Alexander Swan, Do, DO
Emergency Medicine — Payments: $368.13